- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Astramorph, Infumorph, Kadian, Mitigo, MS Contin
Synonyms :
Class :
Opioid analgesics
Brand Name :
Astramorph, Infumorph, Kadian, Mitigo, MS Contin
Synonyms :
Class :
Opioid analgesics
Dosage forms & Strengths:
Adult:
Injectable solution:
0.5 mg/ml
1 mg/ml
Tablet:
15 mg
30 mg
Capsule:
10 mg
20 mg
30 mg
40 mg
50 mg
60 mg
Suppository:
10 mg
20 mg
30 mg
The interaction may increase the risk of sedation, respiratory depression, and coma
The interaction may increase the risk of sedation, respiratory depression, and coma
The interaction may increase the risk of sedation, respiratory depression, and coma
The interaction may increase the risk of sedation, respiratory depression, and coma
The interaction may increase the risk of sedation, respiratory depression, and coma
Concurrent use within 14 days after pholcodine treatment may lead to serotonin syndrome
may increase the depressant effect of opioid agonists
may increase the depressant effect of opioid agonists
may increase the depressant effect of opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
may have an increased CNS depressant effect when combined with opioid agonists
morphine (Systemic): they may decrease the antiplatelet effect of Antiplatelet Agents (P2Y12 Inhibitors)
morphine (Systemic): they may decrease the antiplatelet effect of Antiplatelet Agents (P2Y12 Inhibitors)
morphine (Systemic): they may decrease the antiplatelet effect of Antiplatelet Agents (P2Y12 Inhibitors)
morphine (Systemic): they may decrease the antiplatelet effect of Antiplatelet Agents (P2Y12 Inhibitors)
morphine (Systemic): they may decrease the antiplatelet effect of Antiplatelet Agents (P2Y12 Inhibitors)
may increase the depressant effect of opioid agonists
may increase the depressant effect of opioid agonists
may increase the depressant effect of opioid agonists
may reduce the serum concentration of anti-platelet agents
may enhance the serum concentration
may increase the CNS depressant effect
may increase the CNS depressant effect of CNS depressants
acrivastine and pseudoephedrine
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may have an increased CNS depressive effect when combined with opioid agonists
may have an increased CNS depressive effect when combined with opioid agonists
may have an increased CNS depressive effect when combined with opioid agonists
may have an increased CNS depressive effect when combined with opioid agonists
may have an increased CNS depressive effect when combined with opioid agonists
may have an increasingly adverse effect when combined with alvimopan
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS Depressants
may increase the CNS depressant effect of CNS Depressants
may increase the CNS depressant effect of CNS Depressants
The interaction may enhance the risk of anaphylaxis
The interaction may enhance the risk of anaphylaxis
The interaction may enhance the risk of anaphylaxis
The interaction may enhance the risk of anaphylaxis
The interaction may enhance the risk of anaphylaxis
they decrease the effect of analgesia of opioid agonists
they decrease the effect of analgesia of opioid agonists
they increase the efficacy of other opioid agonists
they increase the efficacy of other opioid agonists
they increase the efficacy of other opioid agonists
they increase the efficacy of other opioid agonists
it increases the effect of CNS depressants
may decrease the therapeutic effect of opioids
they increase the efficacy of other opioid agonists
they increase the efficacy of other opioid agonists
they increase the efficacy of other opioid agonists
they increase the efficacy of other opioid agonists
they increase the toxicity of opioid agonists
they increase the toxicity of opioid agonists
they increase the toxicity of opioid agonists
they increase the toxicity of opioid agonists
they increase the toxicity of opioid agonists
may decrease the analgesic effect of opioids
may have an increased constipating effect when combined with eluxadoline
may decrease the therapeutic effect when combined with opioid agonists
methylnaltrexone: they may increase the adverse effect of opioid antagonists
samidorphan: they may decrease the therapeutic effect of opioid agonists
may decrease the therapeutic effect of Nalmefene
It may lead to sedation, respiratory depression, and coma
It may lead to sedation, respiratory depression, and coma
It may lead to sedation, respiratory depression, and coma
It may lead to sedation, respiratory depression, and coma
It may lead to sedation, respiratory depression, and coma
The interaction may enhance the hypotensive effects of opioid anti-tussive agents
The interaction may enhance the hypotensive effects of opioid anti-tussive agents
The interaction may enhance the hypotensive effects of opioid anti-tussive agents
The interaction may enhance the hypotensive effects of opioid anti-tussive agents
The interaction may enhance the hypotensive effects of opioid anti-tussive agents
The interaction may enhance the hypotensive effects of opioid anti-tussive agents
The interaction may enhance the hypotensive effects of opioid anti-tussive agents
The interaction may enhance the hypotensive effects of opioid anti-tussive agents
The interaction may enhance the hypotensive effects of opioid anti-tussive agents
The interaction may enhance the hypotensive effects of opioid anti-tussive agents
may enhance the adverse/toxic effect of diuretics
may enhance the adverse/toxic effect of diuretics
may enhance the adverse/toxic effect of diuretics
may enhance the adverse/toxic effect of diuretics
may enhance the adverse/toxic effect of diuretics
may reduce the therapeutic effect of gastrointestinal agents
may reduce the therapeutic effect of gastrointestinal agents
may reduce the therapeutic effect of gastrointestinal agents
may reduce the therapeutic effect of gastrointestinal agents
may reduce the therapeutic effect of gastrointestinal agents
It may enhance the metabolism when combined with dexamethasone
when used with dronabinol increases the CNS suppression
it may reduce the therapeutic effect of gastrointestinal agents
it may reduce the therapeutic effect of gastrointestinal agents
it may reduce the therapeutic effect of gastrointestinal agents
it may reduce the therapeutic effect of gastrointestinal agents
it may reduce the therapeutic effect of gastrointestinal agents
it may enhance the QTc-prolonging effect of QT-Prolonging Anesthetics
it may enhance the QTc-prolonging effect of QT-Prolonging Anesthetics
it may enhance the QTc-prolonging effect of QT-Prolonging Anesthetics
it may enhance the QTc-prolonging effect of QT-Prolonging Anesthetics
it may enhance the QTc-prolonging effect of QT-Prolonging Anesthetics
anticholinergic agents may enhance the adverse/toxic effect of opioid agonists
anticholinergic agents may enhance the adverse/toxic effect of opioid agonists
anticholinergic agents may enhance the adverse/toxic effect of opioid agonists
anticholinergic agents may enhance the adverse/toxic effect of opioid agonists
anticholinergic agents may enhance the adverse/toxic effect of opioid agonists
CNS Depressants may enhance the CNS depressant effect of Opioid agonists
CNS Depressants may enhance the CNS depressant effect of Opioid agonists
CNS Depressants may enhance the CNS depressant effect of Opioid agonists
CNS Depressants may enhance the CNS depressant effect of Opioid agonists
CNS Depressants may enhance the CNS depressant effect of Opioid agonists
CNS depressants increase the CNS depressing effect of alcohol
may increase the CNS depressant effect of opioid agonists
may increase the CNS depressant effect of opioid agonists
may increase the CNS depressant effect of opioid agonists
may increas